The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.

Published in: PLoS medicine (2016)

In a Perspective, Jacqueline Deeen discusses challenges in balancing the individual and population risks and benefits for CYD-TDV (Dengvaxia), the first available dengue vaccine.

Keyphrases

zika virus
dengue virus
aedes aegypti
human health
risk assessment
climate change